To include your compound in the COVID-19 Resource Center, submit it here.

Ixiaro regulatory update

Intercell said FDA approved Ixiaro Japanese Encephalitis (JE) vaccine to include pediatric patients. The product is marketed for

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE